tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gil Blum, 399 are a BUY (97.32%), 8 are a HOLD (1.95%), 3 are a SELL (0.73%).
Analyst Gil Blum, currently employed at NEEDHAM, carries an average stock price target met ratio of 27.65% that have a potential upside of 62.8% achieved within 155 days. Previously, Gil Blum worked at TRUIST.
Gil Blum’s has documented 770 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AUTL, Autolus Therapeutics Ltd at 12-Jan-2026.
Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CELC (CELCUITY LLC) at 6/30/2025. The price target of $29 was fulfilled within 28 days with a profit of $15.65 (117.23%) receiving and performance score of 41.87.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 06-Jan-2022
$2
$0.6 (42.86%)
2 years 1 months 2 days ago
(18-Dec-2023)
0/2 (0%)
$0.7 (53.85%)
Buy
Since 04-May-2021
$2
$0.6 (42.86%)
$36
2 years 6 months 7 days ago
(13-Jul-2023)
0/2 (0%)
$0.59 (41.84%)
Hold
Since 12-Jul-2023
$2
$0.6 (42.86%)
$2
2 years 6 months 8 days ago
(12-Jul-2023)
1/3 (33.33%)
$0.57 (39.86%)
7
Buy
Since 07-Dec-2022
3 years 1 months 13 days ago
(07-Dec-2022)
0/2 (0%)
$13.44 (140.59%)
Buy
Since 27-May-2021
3 years 8 months 3 days ago
(17-May-2022)
0/1 (0%)
$19.05 (212.85%)
Which stock is Gil Blum is most bullish on?
Which stock is Gil Blum is most reserved on?
What Year was the first public recommendation made by Gil Blum?
